The CPI (Maoist)'s 2007 political document clings to a Mao-era strategy: of creating a "liberated zone" and "encircling the cities from the countryside." But the sympathiser was blunt: "That doesn't work anymore."
They can pose a serious threat to newborns and the elderly alike. Especially vulnerable are hospital patients with weakened immunity, often spreading rapidly in ICUs and proving difficult - and sometimes impossible - to treat. Treating carbapenem-resistant Gram-negative bacterial infections is doubly difficult because those bacteria are resistant to some of the most powerful antibiotics."These infections are a daily reality across all age groups," says Dr Abdul Ghafur, infectious disease consultant at Apollo Hospital in India's Chennai city. "We often see patients for whom no antibiotic works - and they die."
The irony is cruel. While the world tries to curb antibiotic overuse, a parallel tragedy plays out quietly in poorer nations: people dying from treatable infections because the right drugs are out of reach."For years, the dominant narrative has been that antibiotics are being overused, but the stark reality is that many people with highly drug-resistant infections in low- and middle-income countries are not getting access to the antibiotics they need," says Dr Jennifer Cohn, GARDP's Global Access Director and senior author of the study.The study examined eight intravenous drugs active against carbapenem-resistant bacteria - ranging from older antibiotics including Colistin to newer ones such as Ceftazidime-avibactam. Of the few available drugs, Tigecycline was the most widely used.
Researchers blame the treatment gap on weak health systems and limited access to effective antibiotics.For example, only 103,647 full treatment courses were procured of Tigecycline across eight countries - far short of the 1.5 million patients who needed them, the study found. This highlighted a major shortfall in the global response to drug-resistant infections.
What prevents patients with drug-resistant infections in India from getting the right antibiotics?
Physicians point to multiple barriers - reaching the right health facility, getting accurate diagnostic tests, and accessing effective drugs. Cost remains a major hurdle, with many of these antibiotics priced far beyond the reach of poorer patients.is releasing her debut studio album.
Read on for what's coming up this week...It’s been a few years since we last saw John Wick, but fans will be gearing up for
, the latest film in the franchise, which comes out on Friday.Set during the events of John Wick: Chapter 3 - Parabellum, the film follows Eve Macarro (Ana de Armas), a ballerina-turned-assassin who uncovers secrets from her family's past.